Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group

• Main Authors: S. B. Fitilev (Author), Yu. F. Glukhov (Author), S. V. Lukyanov (Author), V. I. Kazey (Author), I. B. Bondareva (Author), A. V. Vozzhaev (Author), I. I. Shkrebniova (Author), D. A. Kliuev (Author)
• Format: Book
• Published: LLC "Publisher OKI", 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Relevance. As part of the conducted open non-randomized phase I clinical trial the pharmacokinetics (PK) of the first Russian novel antiplatelet agent Angipur (nonpeptide glycoprotein IIb/IIIa receptor inhibitor) was studied.Aim of the research was to evaluate PK parameters of Angipur in healthy vol...